Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Human Coagulation Factor IV Market by Type (Calcium Ion, Calcium Compounds), By Application (Hospital, Personal Clinic, Others) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Human Coagulation Factor IV Market by Type (Calcium Ion, Calcium Compounds), By Application (Hospital, Personal Clinic, Others) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 195409 3300 Pharma & Healthcare 377 231 Pages 4.8 (32)
                                          

The global human coagulation factor IV market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The growth of this market can be attributed to the increasing prevalence of thrombotic disorders and the rising demand for blood transfusion in developing countries. The global human coagulation factor IV market is segmented on the basis of type, application, and region. On the basis of type, it is classified into calcium ion and calcium compounds. On the basis of application, it is classified into hospital and personal clinic. On the basis of region, it is classified into North America (NA), Latin America (LA), Europe (EU), Asia Pacific (APAC) and Middle East & Africa (MEA). -The global market for Factor IV is expected to grow at a CAGR of 3.5% from 2017 to 2025. -The global market for Factor IV is expected to grow at a CAGR of 3.5% from 2017 to 2025 -Factor IV is used in the treatment of hemophilia A and B, as well as other bleeding disorders. -Factor IV is used in the treatment of hemophilia A and B, as well as other bleeding disorders -Factor IV has been approved by the FDA for use in adults with severe hemophilia A or B who have developed antibodies against clotting factor VIII or IX.

Industry Growth Insights published a new data on “Human Coagulation Factor IV Market”. The research report is titled “Human Coagulation Factor IV Market research by Types (Calcium Ion, Calcium Compounds), By Applications (Hospital, Personal Clinic, Others), By Players/Companies Baxter, Bayer, CSL, Pfizer, Grifols, Biogen, Octapharma, Novo Nordisk, Greencross, Kedrion, BPL, Hualan Bio, RAAS”.

Scope Of The Report

Report Attributes

Report Details

Report Title

Human Coagulation Factor IV Market Research Report

By Type

Calcium Ion, Calcium Compounds

By Application

Hospital, Personal Clinic, Others

By Companies

Baxter, Bayer, CSL, Pfizer, Grifols, Biogen, Octapharma, Novo Nordisk, Greencross, Kedrion, BPL, Hualan Bio, RAAS

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

231

Number of Tables & Figures

162

Customization Available

Yes, the report can be customized as per your need.


Global Human Coagulation Factor IV Industry Outlook


Global Human Coagulation Factor IV Market Report Segments:

The global Human Coagulation Factor IV market is segmented on the basis of:

Types

Calcium Ion, Calcium Compounds

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Hospital, Personal Clinic, Others

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Baxter
  2. Bayer
  3. CSL
  4. Pfizer
  5. Grifols
  6. Biogen
  7. Octapharma
  8. Novo Nordisk
  9. Greencross
  10. Kedrion
  11. BPL
  12. Hualan Bio
  13. RAAS

Global Human Coagulation Factor IV Market Overview


Highlights of The Human Coagulation Factor IV Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Calcium Ion
    2. Calcium Compounds
  1. By Application:

    1. Hospital
    2. Personal Clinic
    3. Others
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Human Coagulation Factor IV Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Human Coagulation Factor IV Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


Human coagulation factor IV is a protein that helps to control the clotting process in the blood. It helps to form clots when blood is cut by other proteins and cells, and it also helps to dissolve clots that have formed.

Some of the major companies in the human coagulation factor iv market are Baxter, Bayer, CSL, Pfizer, Grifols, Biogen, Octapharma, Novo Nordisk, Greencross, Kedrion, BPL, Hualan Bio, RAAS.

The human coagulation factor iv market is expected to grow at a compound annual growth rate of 5.5%.

                                            
1. Executive Summary

2. Assumptions and Acronyms Used

3. Research Methodology

4. Human Coagulation Factor IV Market Overview
   4.1. Introduction
      4.1.1. Market Taxonomy
      4.1.2. Market Definition
   4.2. Macro-Economic Factors
      4.2.1. Industry Outlook
   4.3. Human Coagulation Factor IV Market Dynamics
      4.3.1. Market Drivers
      4.3.2. Market Restraints
      4.3.3. Opportunity
      4.3.4. Market Trends
   4.4. Human Coagulation Factor IV Market - Supply Chain
   4.5. Global Human Coagulation Factor IV Market Forecast
      4.5.1. Human Coagulation Factor IV Market Size (US$ Mn) and Y-o-Y Growth
      4.5.2. Human Coagulation Factor IV Market Size (000’ Units) and Y-o-Y Growth
      4.5.3. Human Coagulation Factor IV Market Absolute $ Opportunity

5. Global Human Coagulation Factor IV Market Analysis and Forecast by Type
   5.1. Market Trends
   5.2. Introduction
      5.2.1. Basis Point Share (BPS) Analysis by Type
      5.2.2. Y-o-Y Growth Projections by Type
   5.3. Human Coagulation Factor IV Market Size and Volume Forecast by Type
      5.3.1. Calcium Ion
      5.3.2. Calcium Compounds
   5.4. Absolute $ Opportunity Assessment by Type
   5.5. Market Attractiveness/Growth Potential Analysis by Type

6. Global Human Coagulation Factor IV Market Analysis and Forecast by Application
   6.1. Market Trends
   6.2. Introduction
      6.2.1. Basis Point Share (BPS) Analysis by Application
      6.2.2. Y-o-Y Growth Projections by Application
   6.3. Human Coagulation Factor IV Market Size and Volume Forecast by Application
      6.3.1. Hospital
      6.3.2. Personal Clinic
      6.3.3. Others
   6.4. Absolute $ Opportunity Assessment by Application
   6.5. Market Attractiveness/Growth Potential Analysis by Application

7. Global Human Coagulation Factor IV Market Analysis and Forecast by Sales Channel
   7.1. Market Trends
   7.2. Introduction
      7.2.1. Basis Point Share (BPS) Analysis by Sales Channel 
      7.2.2. Y-o-Y Growth Projections by Sales Channel
   7.3. Human Coagulation Factor IV Market Size and Volume Forecast by Sales Channel 
      7.3.1. Manufacturer/Distributor/Service Provider
      7.3.2. Aftermarket
   7.4. Absolute $ Opportunity Assessment by Sales Channel
   7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel

8. Global Human Coagulation Factor IV Market Analysis and Forecast by Region
   8.1. Market Trends
   8.2. Introduction
      8.2.1. Basis Point Share (BPS) Analysis by Region
      8.2.2. Y-o-Y Growth Projections by Region
   8.3. Human Coagulation Factor IV Market Size and Volume Forecast by Region
      8.3.1. North America
      8.3.2. Latin America
      8.3.3. Europe
      8.3.4. Asia Pacific
      8.3.5. Middle East and Africa (MEA)
   8.4. Absolute $ Opportunity Assessment by Region
   8.5. Market Attractiveness/Growth Potential Analysis by Region
   8.6. Global Human Coagulation Factor IV Demand Share Forecast, 2019-2026

9. North America Human Coagulation Factor IV Market Analysis and Forecast
   9.1. Introduction
      9.1.1. Basis Point Share (BPS) Analysis by Country
      9.1.2. Y-o-Y Growth Projections by Country
   9.2. North America Human Coagulation Factor IV Market Size and Volume Forecast by Country
      9.2.1. U.S.
      9.2.2. Canada
   9.3. Absolute $ Opportunity Assessment by Country
   9.4. North America Human Coagulation Factor IV Market Size and Volume Forecast by Application
      9.4.1. Hospital
      9.4.2. Personal Clinic
      9.4.3. Others
   9.5. Basis Point Share (BPS) Analysis by Application
   9.6. Y-o-Y Growth Projections by Application
   9.7. North America Human Coagulation Factor IV Market Size and Volume Forecast by Type
      9.7.1. Calcium Ion
      9.7.2. Calcium Compounds
   9.8. Basis Point Share (BPS) Analysis by Type
   9.9. Y-o-Y Growth Projections by Type
   9.10. Market Attractiveness/Growth Potential Analysis
      9.10.1. By Country
      9.10.2. By Product Type
      9.10.3. By Application
      9.10.4. By Sales Channel
   9.11. North America Human Coagulation Factor IV Demand Share Forecast, 2019-2026

10. Latin America Human Coagulation Factor IV Market Analysis and Forecast
   10.1. Introduction
      10.1.1. Basis Point Share (BPS) Analysis by Country
      10.1.2. Y-o-Y Growth Projections by Country
      10.1.3. Latin America Average Pricing Analysis
   10.2. Latin America Human Coagulation Factor IV Market Size and Volume Forecast by Country
      10.2.1. Brazil
      10.2.2. Mexico
      10.2.3. Rest of Latin America
   10.3. Absolute $ Opportunity Assessment by Country
   10.4. Latin America Human Coagulation Factor IV Market Size and Volume Forecast by Application
      10.4.1. Hospital
      10.4.2. Personal Clinic
      10.4.3. Others
   10.5. Basis Point Share (BPS) Analysis by Application
   10.6. Y-o-Y Growth Projections by Application
   10.7. Latin America Human Coagulation Factor IV Market Size and Volume Forecast by Type
      10.7.1. Calcium Ion
      10.7.2. Calcium Compounds
   10.8. Basis Point Share (BPS) Analysis by Type
   10.9. Y-o-Y Growth Projections by Type
   10.10. Market Attractiveness/Growth Potential Analysis
      10.10.1. By Country
      10.10.2. By Product Type
      10.10.3. By Application
      10.10.4. By Sales Channel
   10.11. Latin America Human Coagulation Factor IV Demand Share Forecast, 2019-2026

11. Europe Human Coagulation Factor IV Market Analysis and Forecast
   11.1. Introduction
      11.1.1. Basis Point Share (BPS) Analysis by Country
      11.1.2. Y-o-Y Growth Projections by Country
      11.1.3. Europe Average Pricing Analysis
   11.2. Europe Human Coagulation Factor IV Market Size and Volume Forecast by Country
      11.2.1. Germany
      11.2.2. France
      11.2.3. Italy
      11.2.4. U.K.
      11.2.5. Spain
      11.2.6. Russia
      11.2.7. Rest of Europe
   11.3. Absolute $ Opportunity Assessment by Country
   11.4. Europe Human Coagulation Factor IV Market Size and Volume Forecast by Application
      11.4.1. Hospital
      11.4.2. Personal Clinic
      11.4.3. Others
   11.5. Basis Point Share (BPS) Analysis by Application
   11.6. Y-o-Y Growth Projections by Application
   11.7. Europe Human Coagulation Factor IV Market Size and Volume Forecast by Type
      11.7.1. Calcium Ion
      11.7.2. Calcium Compounds
   11.8. Basis Point Sare (BPS) Analysis by Type
   11.9. Y-o-Y Growth Projections by Type
   11.10. Market Attractiveness/Growth Potential Analysis
      11.10.1. By Country
      11.10.2. By Product Type
      11.10.3. By Application
      11.10.4. By Sales Channel
   11.11. Europe Human Coagulation Factor IV Demand Share, 2019-2026

12. Asia Pacific Human Coagulation Factor IV Market Analysis and Forecast
   12.1. Introduction
      12.1.1. Basis Point Share (BPS) Analysis by Country
      12.1.2. Y-o-Y Growth Projections by Country
      12.1.3. Asia Pacific Average Pricing Analysis
   12.2. Asia Pacific Human Coagulation Factor IV Market Size and Volume Forecast by Country
      12.2.1. China
      12.2.2. Japan
      12.2.3. South Korea
      12.2.4. India
      12.2.5. Australia
      12.2.6. Rest of Asia Pacific (APAC)
   12.3. Absolute $ Opportunity Assessment by Country
   12.4. Asia Pacific Human Coagulation Factor IV Market Size and Volume Forecast by Application
      12.4.1. Hospital
      12.4.2. Personal Clinic
      12.4.3. Others
   12.5. Basis Point Share (BPS) Analysis by Application
   12.6. Y-o-Y Growth Projections by Application
   12.7. Asia Pacific Human Coagulation Factor IV Market Size and Volume Forecast by Type
      12.7.1. Calcium Ion
      12.7.2. Calcium Compounds
   12.8. Basis Point Share (BPS) Analysis by Type
   12.9. Y-o-Y Growth Projections by Type
   12.10. Market Attractiveness/Growth Potential Analysis
      12.10.1. By Country
      12.10.2. By Product Type
      12.10.3. By Application
      12.10.4. By Sales Channel
   12.11. Asia Pacific Human Coagulation Factor IV Demand Share, 2019-2026

13. Middle East & Africa Human Coagulation Factor IV Market Analysis and Forecast
   13.1. Introduction
      13.1.1. Basis Point Share (BPS) Analysis by Country
      13.1.2. Y-o-Y Growth Projections by Country
      13.1.3. Asia Pacific Average Pricing Analysis
   13.2. Middle East & Africa Human Coagulation Factor IV Market Size and Volume Forecast by Country
      13.2.1. Saudi Arabia
      13.2.2. South Africa
      13.2.3. UAE
      13.2.4. Rest of Middle East & Africa (MEA)
   13.3. Absolute $ Opportunity Assessment by Country
   13.4. Middle East & Africa Human Coagulation Factor IV Market Size and Volume Forecast by Application
      13.4.1. Hospital
      13.4.2. Personal Clinic
      13.4.3. Others
   13.5. Basis Point Share (BPS) Analysis by Application
   13.6. Y-o-Y Growth Projections by Application
   13.7. Middle East & Africa Human Coagulation Factor IV Market Size and Volume Forecast by Type
      13.7.1. Calcium Ion
      13.7.2. Calcium Compounds
   13.8. Basis Point Share (BPS) Analysis by Type
   13.9. Y-o-Y Growth Projections by Type
   13.10. Market Attractiveness/Growth Potential Analysis
      13.10.1. By Country
      13.10.2. By Product Type
      13.10.3. By Application
      13.10.4. By Sales Channel
   13.11. Middle East & Africa Human Coagulation Factor IV Demand Share, 2019-2026

14. Competition Landscape
   14.1. Global Human Coagulation Factor IV Market: Market Share Analysis
   14.2. Human Coagulation Factor IV Distributors and Customers
   14.3. Human Coagulation Factor IV Market: Competitive Dashboard
   14.4. Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.4.1. Baxter
         14.4.1.1. Overview
         14.4.1.2. Financials
         14.4.1.3. Developments
         14.4.1.4. Strategic Outlook
      14.4.2. Bayer
         14.4.2.1. Overview
         14.4.2.2. Financials
         14.4.2.3. Developments
         14.4.2.4. Strategic Outlook
      14.4.3. CSL
         14.4.3.1. Overview
         14.4.3.2. Financials
         14.4.3.3. Developments
         14.4.3.4. Strategic Outlook
      14.4.4. Pfizer
         14.4.4.1. Overview
         14.4.4.2. Financials
         14.4.4.3. Developments
         14.4.4.4. Strategic Outlook
      14.4.5. Grifols
         14.4.5.1. Overview
         14.4.5.2. Financials
         14.4.5.3. Developments
         14.4.5.4. Strategic Outlook
      14.4.6. Biogen
         14.4.6.1. Overview
         14.4.6.2. Financials
         14.4.6.3. Developments
         14.4.6.4. Strategic Outlook
      14.4.7. Octapharma
         14.4.7.1. Overview
         14.4.7.2. Financials
         14.4.7.3. Developments
         14.4.7.4. Strategic Outlook
      14.4.8. Novo Nordisk
         14.4.8.1. Overview
         14.4.8.2. Financials
         14.4.8.3. Developments
         14.4.8.4. Strategic Outlook
      14.4.9. Greencross
         14.4.9.1. Overview
         14.4.9.2. Financials
         14.4.9.3. Developments
         14.4.9.4. Strategic Outlook
      14.4.10. Kedrion
         14.4.10.1. Overview
         14.4.10.2. Financials
         14.4.10.3. Developments
         14.4.10.4. Strategic Outlook
      14.4.11. BPL
         14.4.11.1. Overview
         14.4.11.2. Financials
         14.4.11.3. Developments
         14.4.11.4. Strategic Outlook
      14.4.12. Hualan Bio
         14.4.12.1. Overview
         14.4.12.2. Financials
         14.4.12.3. Developments
         14.4.12.4. Strategic Outlook
      14.4.13. RAAS
         14.4.13.1. Overview
         14.4.13.2. Financials
         14.4.13.3. Developments
         14.4.13.4. Strategic Outlook
      14.4.14. COMPANY 14
         14.4.14.1. Overview
         14.4.14.2. Financials
         14.4.14.3. Developments
         14.4.14.4. Strategic Outlook
      14.4.15. COMPANY 15
         14.4.15.1. Overview
         14.4.15.2. Financials
         14.4.15.3. Developments
         14.4.15.4. Strategic Outlook
      14.4.16. COMPANY 16
         14.4.16.1. Overview
         14.4.16.2. Financials
         14.4.16.3. Developments
         14.4.16.4. Strategic Outlook
      14.4.17. COMPANY 17
         14.4.17.1. Overview
         14.4.17.2. Financials
         14.4.17.3. Developments
         14.4.17.4. Strategic Outlook
      14.4.18. COMPANY 18
         14.4.18.1. Overview
         14.4.18.2. Financials
         14.4.18.3. Developments
         14.4.18.4. Strategic Outlook
      14.4.19. COMPANY 19
         14.4.19.1. Overview
         14.4.19.2. Financials
         14.4.19.3. Developments
         14.4.19.4. Strategic Outlook
      14.4.20. COMPANY 20
         14.4.20.1. Overview
         14.4.20.2. Financials
         14.4.20.3. Developments
         14.4.20.4. Strategic Outlook

Our Trusted Clients

Contact Us